| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,639.82× | 1,639.82× | 1,032.12× | 4,811.28× | 4,987.08× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 115.45× | 115.45× | 90.41× | 84.79× | 82.67× | ||
| 8,404.10× | 8,404.10× | 4,210.55× | 14,044.53× | 11,711.30× | ||
| −6,648.83× | −6,648.83× | −3,088.02× | −9,148.46× | −6,641.55× | ||
| 5.57× | 5.63× | 6.33× | 6.17× | 19.89× | ||
| 0.86× | 0.86× | 0.91× | 0.81× | 0.67× | ||
| 0.59× | 0.59× | 1.18× | 0.18× | −1.58× | ||
| 0.71× | 0.71× | 1.05× | 0.14× | −1.29× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 4,987.08 | 4,811.28 | 1,032.12 | 1,639.82 | 1,639.82 | |
| Receivable Days (DSO) | 82.67 | 84.79 | 90.41 | 115.45 | 115.45 | |
| Payable Days (DPO) | 11,711.30 | 14,044.53 | 4,210.55 | 8,404.10 | 8,404.10 | |
| Cash Conversion Cycle (days) | -6,641.55 | -9,148.46 | -3,088.02 | -6,648.83 | -6,648.83 | |
| Working Capital Turnover | 19.89 | 6.17 | 6.33 | 5.63 | 5.57 | |
| Asset Turnover | 0.67 | 0.81 | 0.91 | 0.86 | 0.86 | |
| Cash Conversion (CFO/Net Income) | -1.58 | 0.18 | 1.18 | 0.59 | 0.59 | |
| CFO/EBITDA | -1.29 | 0.14 | 1.05 | 0.71 | 0.71 |